In addition, antivirals are often only effective against a narrow spectrum of viruses. To better combat future viral pandemics, it is essential to have drugs with broad antiviral activity that can ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
In this scenario, NV-387 stands apart in the field of antiviral countermeasures in ... and (ii) the activity spectrum of NV-387 is so broad, encompassing not just a type of virus, but across ...
In this scenario, NV-387 stands apart in the field of antiviral countermeasures in that escape of virus even as it evolves is highly unlikely. This is because (i) NV-387 mimics the essential host-side ...
Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...
Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...